IJCM  Vol.2 No.2 , May 2011
Basal Cell Carcinoma: Experience in a Teaching Hospital, Calabar-South Nigeria
ABSTRACT
Background: Basal cell carcinoma (BCC) is the commonest malignancy among Caucasians in Europe, North America, and Australia. This study attempted to identify the prevalence, risk factors, and outcome of management of this problem in our region. Methods: All the patients with histologic diagnosis of BCC presenting to the University of Calabar Teaching Hospital, Calabar during the study period January 2000 to December 2009 were evaluated. Results: One hundred and fifty two patients (136 blacks, 16 albinos) were afflicted with skin malignancy, squamous cell carcinoma and BCC totaled 70 [SCC – 62, BCC – 8], and malignant melanoma (MM) – 16. Of the 8 patients, (3 males and 5 females, mean age 43 years, range 21-65 years) observed with BCC lesions, 2 (25%) were darkly pigmented and 6 (75%) were albinos. Most of the albinos who presented 3 decades before the darkly pigmented ranged in age from 21-60 years (mean 35.7 years). The lesions afflicted the head and neck region, 9 (82%), while 2 (18%) were observed on the upper limb. All the patients had excision with satisfactory results during the period of follow up that ranged from 6 months to 3 years (mean 13 months). Conclusion: BCC is an uncommon lesion in our region. Albinism and solar radiation were identified risk factors. Most of the albinos presented 3 decades earlier than the darkly pigmented. Early institution of preventive measures, early diagnosis, and treatment would result in better outcome.

Cite this paper
nullA. Maurice, O. Otei, N. Victor, E. Godwin and O. Joshua, "Basal Cell Carcinoma: Experience in a Teaching Hospital, Calabar-South Nigeria," International Journal of Clinical Medicine, Vol. 2 No. 2, 2011, pp. 93-96. doi: 10.4236/ijcm.2011.22019.
References
[1]   [1] R. S. Bader, L. Santacroce and A. S. Kenedy, “Basal Cell Carcinoma,” August 31st, 2009. http://emedicine.medscape.com/article/276624-overview

[2]   [2] T. L. Diepgen and V. Mahler, “The Epidemiology of Skin Cancer,” British Journal of Dermatology, Vol. 61, Suppl. S61, 2002, pp. 1-6.

[3]   [3] N. D. Gross, M. Monroe, “Skin Cancer, Squamous Cell Carcinoma,” January 15th, 2009. http://emedicine.medscape.com/article/870430-overview. Accessed

[4]   [4] M. Situm, M. Buljan, V. Bulat, L. Lugovic Mitel, Z. Bo-lanca and D. Simic, “The Role of UV Radiation in the Development of Basal Cell Carcinoma,” Collegium An-tropologicum, Vol. 32, Suppl. 2, 2008, pp. 167-170.

[5]   [5] M. E. Asuquo, P. Agweye, G. Ugare and G. Ebughe, “Basal Cell Carcinoma in Five Albino Africans from the South-Eastern Equatorial Rain Forest of Nigeria,” Inter-national Journal of Dermatolgy, Vol. 46, No. 7, 2007, pp. 754-756. doi:10.1111/j.1365-4632.2007.03272.x

[6]   [6] M. Buljan, V. Bulat, M. Situm, L. L. Mihic and S. Stan-ic-Duktaj, “Variations in Clinical Presentation of Basal Cell Carcinoma,” Acta Clinica Croatica, Vol. 47, No. 1, 2008, pp. 25-30.

[7]   [7] B. A. Raasch, P. G. Bueffner and C. Garbe, “Basal Cell Carcinoma: Histological Classification and Body Site Distribution,” British Journal of Dermatology, Vol. 155, No. 2, 2006, pp. 401-407. doi:10.1111/j.1365-2133.2006.07234.x

[8]   [8] M. E. Asuquo, O. Ngim, G. Ugare, J. Omotoso and G. Ebughe, “Major Dermatological Malignancies Encoun-tered in a Teaching Hospital Surgical Department in South Nigeria,” American Journal of Clinical Dermatol-ogy, Vol. 9, No. 6, 2008, pp. 383-387. doi:10.2165/0128071-200809060-00004

[9]   [9] O. Ochicha, S. T. Edino, A. Z. Mohammed and A. B. Umar, “Dermatological Malignancies in Kano, Northern Nigeria: A Histopathological Review,” Annals of African Medicine, Vol. 3, No. 4, 2004, pp. 188-191.

[10]   [10] B. M. Mandong, K. S. Orkar, A. Z. Sule and N. L. Da-kum, “Malignant Skin Tumours in Jos University Teach-ing Hospital, Jos, Nigeria,” Nigerian Journal of Surgical Research, Vol. 3, No. 1, 2000, pp. 29-33.

[11]   [11] I. A. Adigun, M. O. Buhari and R. O. Ayorinde, “Malig-nant Skin Tumours in Blacks: Experience in a Teaching Hospital,” West African Journal of Medicine, Vol. 25, No. 4, 2006, pp. 276-278.

[12]   [12] A. Altman, T. Rosen, J. A. Tschen, T. Hoffman, S. Bruce, D. M. Siegel, M. L. Levy, D. Schaefer and L. H. Gold-berg, “Basal Cell Epithelioma in Black Patients,” Journal of American Academy Dermatology, Vol. 17, No. 5, 1987, pp. 741-745. doi:10.1016/S0190-9622(87)70256-4

[13]   [13] W. Lear, E. Dahlke, C. A. Murray, “Basal Cell Carci-noma: Review of Epidemiology, Pathogenesis and Asso-ciated Risk Factors,” Journal of Cutaneous Medicine and Surgery, Vol. 11, No. 1, 2007, pp. 19-30.

[14]   [14] A. Yakubu and A. Mabogunje, “Skin Cancer in Zaria, Nigeria,” Tropical Doctor, Vol. 25, Suppl. 1, 1995, pp. 63-67.

[15]   [15] S. A. Ademiluyi, G. T. Ijaduola, “Occurrence and Recur-rence of Basal Cell Carcinoma of the Head and Neck in Negroid and Albino Africans,” Journal of Laryngology and Otology, Vol. 101, No. 12, 1987, pp. 1324-1328. doi:10.1017/S0022215100103780

[16]   [16] J. Roewert-Huber, B. Lange-Asschenfeldt, E. Stockfelth, and H. Kert, “Epidemiology and Aetiology of Basal Cell Carcinoma,” British Journal of Dermatol, Vol. 157, Suppl. 2, 2007, pp. 47-51. doi:10.1111/j.1365-2133.2007.08273.x

[17]   [17] L. Chorin, J. E. Nirris and M. Gupta, “Basal Cell Carci-noma in Blacks: A Report of 15 Cases,” Annals of Plastic Surgery, Vol. 33, No. 1, 1994, pp. 90-95. doi:10.1097/00000637-199407000-00019

 
 
Top